You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 5, 2018

APFI Food Safety Regulations Series: Vietnam

Asia Pacific Food Industry (APFI)

To better understand the food regulatory landscape in Asia, APFI has spoken to law firms that specialize in food law from five different countries across Asia, which include China, Thailand, Vietnam, Singapore and the Philippines. 

In the third part of the series, we look at food safety regulations in Vietnam. Hien Thi Thu Vu, head of regulatory affairs, Vietnam, Tilleke & Gibbins, shares her advice.

How do food regulation and registration vary depending on the product or category?

Food products, depending on the product category, are regulated and managed by three different ministries: the Ministry of Health (MOH), the Ministry of Industry and Trade (MOIT), and the Ministry of Agriculture and Rural Development (MARD). The MOH has the prevailing general management power.

These ministries have issued three lists of foods, specifying which food belongs to the management of which ministry. The MOH, for example, is in charge of bottled water, functional foods, and nutraceuticals; the MOIT is in charge of wine, beer, and candy; and the MARD is in charge of cereals, meat and meat products, and seafood. This classification affects a number of things, including which authority carries out food safety inspection.

Regardless of their categories, all foreign processed foods must be registered with the Vietnam Food Administration (VFA)—an agency of the MOH—to obtain a Certificate of Conformity Declaration (CCD) before being imported into and/or circulated in the Vietnam market.

Processed foods include two main groups: general food products, and nutraceuticals/functional food products. Depending of the group, food products may have to meet different requirements before getting the CCD. For example, a functional food must have a Free Sale Certificate or Health Certificate or an equivalent certificate granted by competent authorities in the country of origin, along with information and scientific documents supporting the effects of each ingredient contributing to the declared functions of the product. General food products are exempt from these requirements, but must provide testing results from within the past 12 months, including key quality criteria and food safety criteria.

It is strictly required that product labels comply with the country’s labelling requirements, such as compulsory contents in the Vietnamese language.

Have you seen a growth in the number of food and beverage companies entering the markets in Vietnam?

Yes, the market is growing fast and the game is growing more and more competitive. Food and beverage conferences and exhibitions regularly attract hundreds of companies from Europe, Asia, and the Americas looking to introduce their products to the Vietnam market, and business advocates like the European Business Network in Vietnam and the American Chamber of Commerce have organized trade promotion activities in sectors such as canned food, milk, beer, and wine. The launch of the European Union-Vietnam Free Trade Agreement is certain to open the market further to European food and beverage companies.

At present, many foreign businesses are investing in the country’s food and beverage market through mergers and acquisitions to own shares in many of the nation’s domestic companies, such as Kido Group, Dabaco, and Masan Nutri-Science. More than 50 percent of the local beverage market is now owned by foreign businesses.

Which regulatory hurdles should manufacturers be aware of when entering the food market in Vietnam?

When it comes to preparing for market launch, there are some regulatory hurdles that foreign food manufacturers and distributors will inevitably encounter in Vietnam.

The general regulations on the levels, criteria, and requirements for heavy metals, pollutants, microorganisms, etc., related to food safety and hygiene for human health issued by the Ministry of Health have not been updated since 2011, and are not in line with corresponding standards in other countries where the products are often produced.

Although there is an online submission system for registering products in Vietnam, government agencies still require manufacturers to submit original documents such as the Certificate of Analysis, Hazard Analysis and Critical Control Points, and ISO 22000 certificates. This slows down the registration process of the product.

Some labelling regulations are not flexible enough to cover exceptions in special cases, such as beverages sold exclusively to bars, and food sold exclusively to manufacturers’ store systems.

Foods circulating in the market are subject to periodic quality testing. At present, however, many labs in Vietnam do not have high-quality operations, which can lead to inaccurate test results, affecting the test quality of products. This in turn can lead to products not being in conformity with the documents registered with government agencies. In this case, the CCD might be revoked, and a sanction may be imposed against the seller/importer.

One common violation of food products is in labelling, when the information on the label is different from the information submitted to the VFA or when the label changes without notice being sent to the VFA. This can result in a fine being imposed on the seller/importer, and the goods being withdrawn from the market. Manufacturers should closely monitor any changes in their products and labels to ensure compliance.

Do you predict any major changes to transpire in Vitnam’s food industry in the next five to ten years?

With a population approaching 100 million, strong gross domestic product growth, rising per capita income, rapid urbanization, and growing concerns about food safety from consumers, Vietnam’s market is promising even more growth and development in the coming time, especially for foreign manufacturers.

The legal regulations for food and drinks are becoming more transparent. There have been some updates of regulatory requirements which facilitate the market launch of products. For example, online submission will be encouraged for registration of food and beverage products, and this process is expected to save time and money for suppliers.

The safety and quality of food is a growing concern for consumers as well as state regulators:

  • Products from highly reputable foreign companies, especially in baby food and health foods, will be more and more in demand.
  • State management agencies will intensify the frequency of inspection of various stages of the manufacturing processes. Non-compliant activities could lead to sanctions such as product recall.

Are there any other thoughts you would like to share with our readers?

Already promising and potentially hugely profitable, the food and beverage market is still growing. There will be increasingly more room and opportunity for foreign manufacturers. In parallel with income growth, consumers are becoming increasingly more selective about their food and drink purchases, particularly the quality and safety of the products, and are willing to spend more for a better choice.

Though seemingly clear and detailed, Vietnam’s legal regulations can be unpredictable in practice, with many grey areas, jurisdictional overlap, and contradictions to cope with. However, we believe that with the growing effort of the government to cut through the red tape, the regulatory hurdles will be significantly lowered in the future.

Please provide an overview of what the firm does.

Tilleke & Gibbins is a regional law firm in Southeast Asia, with 150 lawyers and consultants in Bangkok, Hanoi, Ho Chi Minh City, Jakarta, Phnom Penh, Vientiane, and Yangon. We represent investors and companies in the key areas of commercial transactions as well as mergers and acquisitions, dispute resolution and litigation, and intellectual property.

One of our important practice areas is regulatory affairs, where we assist companies in the pharmaceutical, cosmetics, consumer products, food and beverages, biotech, medical devices, veterinary products, and other life sciences sectors to enter markets throughout Southeast Asia. We assist companies in research and development and clinical trials to registration and market entry to commercialization and technology transfer, through every stage of a product’s life cycle.

Our Regulatory Affairs practice spans the following disciplines:

  • Clinical Trials and Consumer Testing
  • Registration with Vietnam Food Administration (VFA) or Drug Administration of Vietnam (DAV)
  • Import, Export, and Manufacturing Licenses
  • Ministry of Agriculture and Rural Development (MARD) Crop Care Registration
  • MARD Animal, Aquatic, and Hazardous Substance Registration
  • MARD Import, Export, and Manufacturing Licenses
  • Regulatory Compliance and Maintenance
  • Labeling and Advertising Clearance
  • Intellectual Property

Article by Farah Nazurah Source: http://apfoodonline.com/industry/food-safety-regulations-series-vietnam/

RELATED INSIGHTS​ 

January 8, 2026
Thailand’s approach to cannabis regulation has moved quickly from broad access to a medical, prescription‑only system. The latest government regulation classifies the cannabis flower as a controlled herb under the Thai Traditional Medicine Wisdom Act. The latest rules ban advertising and recreational sales, allow sales only to patients with prescriptions (up to 30 days), and require flowers to come from GACP‑certified (Good Agricultural and Collection Practices) farms. More importantly, cannabis dispensaries can only sell to patients presenting valid prescriptions issued by one of seven professions—medical doctors, Thai traditional practitioners, applied Thai traditional practitioners, traditional Chinese medicine practitioners, pharmacists, dentists, and folk healers—consistent with approved clinical indications. Noncompliance risks license suspension or revocation, and criminal penalties of up to one year’s imprisonment or a THB 20,000 fine. The dispensary‑only model that proliferated in Thailand in recent years is expected to end soon, as the rules will push all cannabis dispensaries into medical settings or retail pharmacies. Dispensaries must convert into medical establishments—clinics, pharmacies, or traditional pharmacies—complete with on‑site licensed practitioners as well as budtenders; strong controls for storage, hygiene, odor, and smoke; and facilities for record-keeping. All flowers dispensed or exported must come from GACP‑certified farms. If the government ends dispensaries outright and forces a conversion to clinics or pharmacies, compensation will not be automatic at the outset. As a result, business operators should plan for compliance and repurposing under the Medical Facilities Act, Modern Drug Act, and Herbal Product Act, which regulate medical clinics, modern pharmacies, and traditional medicine pharmacies, respectively. The table below summarizes the required licenses for clinics, pharmacies, and traditional medicine pharmacies selling cannabis flowers in Thailand. Aside from the specific listed licenses, all three types of establishments must also obtain a license to sell a controlled herb (cannabis flowers) from the Department of Thai Traditional
January 6, 2026
On December 30, 2025, Thailand’s Electronic Transactions Development Agency (ETDA) notified digital marketplace operators of a consolidated list of “high‑risk products” that are subject to strict monitoring on digital platforms. The list was jointly prepared by the Thai Industrial Standards Institute (TISI) and the Food and Drug Administration (FDA) to guide platform compliance in the initial phase of implementation of the Electronic Transaction Committee’s Notification on Other Measures for Marketplace for Goods with Specific Characteristics under Section 18(2) of the 2022 Royal Decree on Digital Platform Businesses Requiring Notification B.E.2568 (2025). The notice is addressed to operators of digital platform services that function as product marketplaces with specific characteristics laid out in the notification. The ETDA states that the TISI and the FDA are closely monitoring the high‑risk product categories on digital platforms, and the published list serves as the baseline reference for platform screening during the initial phase of the notification’s implementation. High‑Risk Product List The list aggregates categories of products that are illegal to sell online or are otherwise tightly regulated under Thai law, with an emphasis on health-related products, controlled substances, medical devices, and a wide range of industrial products that require certification or compliance with specified Thai Industrial Standards, as detailed below. Prohibited and tightly controlled health products. This includes all categories of modern medicines subject to control other than general household remedies; all categories of controlled herbal products except for over-the-counter herbal products; narcotics; psychotropic substances; and medical devices requiring use in medical facilities or a physician’s prescription. Selected industrial products requiring heightened controls. The list highlights dozens of TISI-regulated items commonly sold online. Examples include pacifiers, rice cookers, electrical wire, food wrap film, crayons, washing machines and dryers, air conditioners, electric cookers and air fryers, water heaters, microwave ovens, LED luminaires, hair dryers
January 5, 2026
On December 31, 2025, Vietnam’s Ministry of Health (MOH) issued Circular No. 57/2025/TT-BYT providing guidance on the classification of medical devices according to technical standards and quality requirements (Circular 57), applicable to procurement activities for medical devices in Vietnam. According to the MOH, the purpose of the classification is to establish a principle-based legal framework and regulations that enable purchasers to easily identify groups of medical devices aligned with their professional requirements and financial capacity. Some of the key stipulations of Circular 57 are outlined below. Basis for Determining Technical Standards and Quality Under Circular 57, the technical standards of medical devices are determined in accordance with Vietnamese laws on standards and technical regulations, through the following means: Certification of conformity with standards in accordance with Vietnamese laws on standards and technical regulations; Results of conformity assessment conducted by an internationally recognized conformity assessment organization or a legally established domestic or foreign conformity assessment organization operating in Vietnam; and Documentation evidencing compliance provided by the medical device owner. The quality of medical devices is determined based on whether the device has been approved for circulation by the relevant marketing authority of one or more jurisdictions. Classification of Medical Devices Circular 57 classifies medical devices into six groups (from Group 1 to Group 6) based on technical standards and quality. Medical devices subject to classification must simultaneously meet technical standards and quality requirements in accordance with professional specifications and user needs, and must be lawfully marketed in Vietnam. Medical devices manufactured in Vietnam may participate in all corresponding groups, provided they meet the technical standards required by the user and are lawfully marketed in Vietnam. Outlook Circular No. 57 will take effect on February 15, 2026, while the classification requirements will become effective on January 1, 2027. Holders of medical
December 30, 2025
The Intellectual Property Office of Vietnam (IP Office), with support from the Japan International Cooperation Agency (JICA), is drafting additional annexes to its Guidelines for Patent Examination, focusing on the examination of patent applications in the pharmaceutical and biotechnology sectors. The new annexes are expected to be officially issued in early 2026 as Annexes III and IV, following the successful issuance in 2023 of Annexes I and II addressing computer program-related inventions. The IP Office recently organized a seminar to gather feedback on the draft annexes from intellectual property representatives, academic institutions, research institutes, and other interested parties, emphasizing its intention to receive further constructive opinions to refine the guidelines for pharmaceuticals and biotechnology. Why These Guidelines Matter Patent examination in Vietnam has traditionally relied on the Guidelines for Patent Examination issued under Decision No. 487/QD-SHTT (2010), recently supplemented by Annexes I and II. While these documents provide a solid foundation, they do not fully address practical challenges in examining pharmaceutical and biotech inventions, particularly issues related to clarity, sufficiency of disclosure, enablement, features of function and utility, combination therapies, and inventions involving artificial intelligence (AI) applications in these fields. Annexes III and IV aim to close these gaps by introducing structured principles and illustrative examples. Guidance on Patent Specification Requirements Annex III provides detailed guidance on the requirements for patent specifications in pharmaceuticals and biotechnology, covering two main parts: Part A addresses sufficiency of disclosure, clarity of specifications, and consistency between claims and descriptions. Part B covers inventions related to Markush-type compounds, claims containing exclusion statements (disclaimers), and additional experimental data submitted during examination. The Guidelines outline specific disclosure requirements for subject matters such as compounds, formulations, pharmaceutical compositions, genes, polypeptides, proteins, vectors, transgenic organisms, modified organisms, and hybrid cells. Annex III emphasizes that disclaimers are not accepted